Related Experiment Video
Updated: Apr 23, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
1.1K
Biomarkers in psoriatic arthritis: recent progress
1Department of Medicine, Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada, vchandra@uhnresearch.ca.
Current Rheumatology Reports
|September 15, 2014
Summary
Identifying biomarkers for psoriatic arthritis (PsA) is crucial for early detection and management. Ongoing research explores genomic, proteomic, and imaging markers to improve patient outcomes.
Area of Science:
- Rheumatology
- Immunology
- Biomarker Discovery
Background:
- Psoriatic arthritis (PsA) is an inflammatory condition linked to psoriasis, affecting approximately 25% of skin psoriasis patients.
- Predicting PsA development and progression in individuals with psoriasis remains a significant clinical challenge.
- There is a critical need for validated biomarkers to guide screening, assess disease activity, monitor joint damage, predict treatment response, and manage comorbidities in PsA.
Purpose of the Study:
- To review recent advancements in biomarker research for psoriatic arthritis.
- To discuss the potential clinical implications of novel biomarkers in PsA pathogenesis, diagnosis, and therapy.
Main Methods:
- Review of current literature on psoriatic arthritis biomarker research.
- Inclusion of findings from genomic, proteomic, cellular, tissue, and imaging (ultrasonography) studies.
- Discussion of emerging biomarkers, including soluble proteins and microbiomics.
Main Results:
- Multiple research avenues, including omics and imaging, are yielding new potential biomarkers for PsA.
- While promising, no biomarkers have yet been clinically validated for psoriatic arthritis.
- Discovery studies are ongoing, and validation cohorts are being established.
Conclusions:
- Significant progress has been made in identifying potential biomarkers for psoriatic arthritis.
- Further research and validation are necessary before these biomarkers can be implemented in clinical practice.
- Biomarker discovery holds promise for improving the diagnosis, prognosis, and treatment of PsA.
